Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

Solomon, S. et al. (2004) Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 110, pp. 2180-2183. (doi: 10.1161/01.CIR.0000144474.65922.AA)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Solomon, S., Wang, D., Finn, P., Skali, H., Zornoff, L., McMurray, J., Swedberg, K., Yusuf, S., Granger, C., Michelson, E., Pocock, S., and Pfeffer, M.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Circulation

University Staff: Request a correction | Enlighten Editors: Update this record